Polikistik Over Sendromunda Uyku Kalitesi, Huzursuz Bacaklar Sendromu, Anksiyete ve Depresyonun Değerlendirilmesi
PDF
Atıf
Paylaş
Talep
P: 243-249
Eylül 2021

Polikistik Over Sendromunda Uyku Kalitesi, Huzursuz Bacaklar Sendromu, Anksiyete ve Depresyonun Değerlendirilmesi

J Turk Sleep Med 2021;8(3):243-249
Bilgi mevcut değil.
Bilgi mevcut değil
Alındığı Tarih: 29.01.2021
Kabul Tarihi: 11.06.2021
Yayın Tarihi: 11.08.2021
PDF
Atıf
Paylaş
Talep

ÖZET

Amaç:

Çalışmanın amacı, polikistik over sendromlu (PKOS) hastalarda uyku bozukluklarını araştırmak ve uyku bozuklukları ile PKOS’un metabolik ve psikojenik yönleri arasındaki ilişkiyi belirlemektir.

Gereç ve Yöntem:

Bu olgu kontrol çalışması 1 Ekim 2019-1 Mart 2020 tarihleri arasında bir üçüncü basamak hastanenin jinekoloji ve nöroloji polikliniklerinde yapıldı. Çalışmaya PKOS tanısı almış 73 hasta ve 63 sağlıklı gönüllü kadın dahil edildi. Tüm katılımcıların testosteron, açlık glikozu ve açlık insülin seviyeleri ölçüldü. Tüm çalışma katılımcıları Beck depresyon ölçeği (BDÖ), Beck anksiyete ölçeği (BAÖ), Epworth uykululuk ölçeği (EUÖ), Berlin anketi (BA), uykusuzluk şiddet indeksi (UŞİ) ve Pittsburgh uyku kalitesi indeksini (PUKİ) tamamladı. Huzursuz bacaklar sendromu (HBS) varlığı uluslararası HBS çalışma grubu kriterlerine göre değerlendirildi.

Bulgular:

PUKİ skorlarına göre, PKOS hastalarının %61,6’sı ve sağlıklı kontrollerin %34.9’u kötü uyku kalitesine sahipti (p=0.003). PKOS grubu kontrol grubuna göre anlamlı olarak daha yüksek PUKİ, EUÖ, UŞİ, BAÖ, BDÖ ve BA skorlarına sahipti (sırasıyla; p=0.002, p=0.001, p<0.001, p<0.001, p<0.001, p<0.001) PKOS hastalarının %23.3'ü HBS kriterlerini karşılarken bu oran kontrol grubunda sadece %6.3 idi (p=0.013). İnsülin direnci ile PSQI arasında pozitif korelasyon vardı (r=0.320, p=0.006).

Sonuç:

Bu çalışmanın sonuçları, PKOS’nin birçok uyku bozukluğu için bir risk faktörü olabileceğini göstermektedir. Ayrıca PKOS’un neden olduğu hem organik hem de psikojenik değişikliklerin kümülatif etkisi uyku bozukluklarına neden olabilir.

References

1
Casadei L, Fanisio F, Sorge RP, Collamarini M, Piccolo E, Piccione E. The diagnosis of PCOS in young infertile women according to different diagnostic criteria: the role of serum anti-Müllerian hormone. Arch Gynecol Obstet 2018;298:207-15.
2
Antonio L, Pauwels S, Laurent MR, Vanschoubroeck D, Jans I, Billen J, Claessens F, Decallonne B, De Neubourg D, Vermeersch P, Vanderschueren D. Free testosterone reflects metabolic as well as ovarian disturbances in subfertile oligomenorrheic women. Int J Endocrinol 2018;2018:7956951. https://doi:10.1155/2018/7956951.
3
Dumesic DA, Phan JD, Leung KL, Grogan TR, Ding X, Li X, Hoyos LR, Abbott DH, Chazenbalk GD. Adipose insulin resistance in normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2019;104:2171-83.
4
Randeva HS, Tan BK, Weickert MO, Lois K, Nestler JE, Sattar N, Lehnert H. Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev 2012;33:812-41.
5
Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41.
6
Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ; International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod 2018;33:1602-18.
7
Nandalike K, Strauss T, Agarwal C, Coupey SM, Sin S, Rajpathak S, Cohen HW, Arens R. Screening for sleep-disordered breathing and excessive daytime sleepiness in adolescent girls with polycystic ovarian syndrome. J Pediatr 2011;159:591-6.
8
Kahal H, Kyrou I, Tahrani AA, Randeva HS. Obstructive sleep apnoea and polycystic ovary syndrome: A comprehensive review of clinical interactions and underlying pathophysiology. Clin Endocrinol (Oxf) 2017;87:313-9.
9
Viola-Saltzman M. Restless legs syndrome and menopause. In: Sleep Disorders in Women: Springer, New York, 2013:261-6.
10
Hübner A, Krafft A, Gadient S, Werth E, Zimmermann R, Bassetti CL. Characteristics and determinants of restless legs syndrome in pregnancy: a prospective study. Neurology 2013;80:738-42.
11
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
12
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
13
Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56:893-7.
14
Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
15
Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
16
Abrishami A, Khajehdehi A, Chung F. A systematic review of screening questionnaires for obstructive sleep apnea. Can J Anaesth 2010;57:423-38.
17
Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001;2:297-307.
18
Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB; International Restless Legs Syndrome Study Group. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep Med 2014;15:860-73.
19
Vgontzas AN, Calhoun S. Polycystic ovary syndrome, sleep apnea, and daytime sleepiness and fatigue. In: Diagnosis and Management of Polycystic Ovary Syndrome. Springer, Newyork, 2009:143-54.
20
Fernandez RC, Moore VM, Van Ryswyk EM, Varcoe TJ, Rodgers RJ, March WA, Moran LJ, Avery JC, McEvoy RD, Davies MJ. Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies. Nat Sci Sleep 2018;10:45-64.
21
Hillman DR, Lack LC. Public health implications of sleep loss: the community burden. Med J Aust. 2013;199:S7-10. doi:10.5694/mja13.10620.
22
Park JG, Ramar K, Olson EJ. Updates on definition, consequences, and management of obstructive sleep apnea. Mayo Clin Proc 2011;86:549-54; quiz 554-5.
23
Vgontzas AN, Legro RS, Bixler EO, Grayev A, Kales A, Chrousos GP. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 2001;86:517-20.
24
Gaines J, Vgontzas AN, Fernandez-Mendoza J, Bixler EO. Obstructive sleep apnea and the metabolic syndrome: the road to clinically-meaningful phenotyping, improved prognosis, and personalized treatment. Sleep Med Rev 2018;42:211-19.
25
Garbarino S, Durando P, Guglielmi O, Dini G, Bersi F, Fornarino S, Toletone A, Chiorri C, Magnavita N. sleep apnea, sleep debt and daytime sleepiness are independently associated with road accidents. a cross-sectional study on truck drivers. PLoS One 2016;11:e0166262. https://10.1371/journal.pone.0166262.
26
Azizi Kutenaee M, Amirjani S, Asemi Z, Taghavi SA, Allan H, Kamalnadian SN, Khashavi Z, Bazarganipour F. The impact of depression, self-esteem, and body image on sleep quality in patients with PCOS: a cross-sectional study. Sleep Breath 2020;24:1027-34.
27
Franik G, Krysta K, Madej P, Gimlewicz-Pięta B, Oślizło B, Trukawka J, Olszanecka-Glinianowicz M. Sleep disturbances in women with polycystic ovary syndrome. Gynecol Endocrinol 2016;32:1014-17.
28
Ohayon MM, O'Hara R, Vitiello MV. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev 2012;16:283-95.
29
Dzaja A, Wehrle R, Lancel M, Pollmächer T. Elevated estradiol plasma levels in women with restless legs during pregnancy. Sleep 2009;32:169-74.
30
Pratt DP. Restless legs syndrome/willis-ekbom disease and periodic limb movements: a comprehensive review of epidemiology, pathophysiology, diagnosis and treatment considerations. Curr Rheumatol Rev 2016;12:91-112.
31
Merlino G, Valente M, Serafini A, Gigli GL. Restless legs syndrome: diagnosis, epidemiology, classification and consequences. Neurol Sci 2007;28(Suppl 1):S37-46.
32
Baran AS, Richert AC, Douglass AB, May W, Ansarin K. Change in periodic limb movement index during treatment of obstructive sleep apnea with continuous positive airway pressure. Sleep 2003;26:717-20.
33
Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2012;18:618-37.
34
Gao X, Schwarzschild MA, Wang H, Ascherio A. Obesity and restless legs syndrome in men and women. Neurology 2009;72:1255-61.
35
Andersen ML, Alvarenga TF, Mazaro-Costa R, Hachul HC, Tufik S. The association of testosterone, sleep, and sexual function in men and women. Brain Res 2011;1416:80-104.
2024 ©️ Galenos Publishing House